SOAT1 and central nervous system cancer: Avasimibe, an acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT1) inhibitor, promotes cell cycle arrest in the G0/G1 and G2/M phases and mitochondrial apoptosis in glioma cells [175].